What are the responsibilities and job description for the Senior Manager, New Product Commercialization position at Alnylam Pharmaceuticals?
This role is considered Hybrid.
Overview
The company has a rich and deep pipeline and is looking to expand its Pipeline Commercialization capability by bringing on a Sr. Manager to support strategic initiatives across various programs in development. This individual will be a critical member of the value and pipeline commercialization team and will report to the global commercial lead of Zilebesiran. They will support Zilebesiran, Alnylam's flagship program in hypertension as well as other programs in development. This individual will partner with program Teams, Medical Affairs, Market Access, as well as other commercial teams to execute strategies that maximizes the value of Alnylam's pipeline.
This position is onsite / hybrid onsite and will be primarily located in Cambridge, MA.
Key Responsibilities
- Lead project management of Early Commercial and Medical Strategy Team meetings for zilebesiran to ensure tracking of key initiatives including execution and impact
- Provide commercial insight and analytical support for commercial assessments and high-level market situation assessments across the pipeline, including business development opportunities
- Together with other pipeline commercial leads, assess and prioritize the commercial opportunity & attractiveness of targets and indications in or approaching early development
- Work closely with forecasting and insights lead to design and execute primary market research studies based on a clear understanding of business questions and objectives
- Synthesize secondary data and knowledge of the competitive environment to inform business strategy
- Develop and communicate a clear view of treatment dynamics : ensuring a common understanding of the disease / treatment experience based on representative input from patients and physicians
- Be a champion for our Patients!
Qualifications
About Alnylam : Alnylam Pharmaceuticals (Nasdaq : ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture : Our people-first culture is guided by our core values : fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
